Ipamorelin Improves Vision in American Males with AMD: A Three-Year Study
Reading Time: 3 minutes Introduction Age-Related Macular Degeneration (AMD) is a leading cause of vision loss among older adults in the United States, affecting millions of individuals, particularly males. Recent research has explored various therapeutic avenues to mitigate the progression of AMD, with a focus on novel pharmacological agents. One such agent, Ipamorelin, a selective growth hormone secretagogue, has been the subject of a comprehensive three-year ophthalmological study. This article delves into the findings of this study, examining Ipamorelin's effects on vision and eye health in American males diagnosed with AMD. Study Design and Methodology The study involved 200 American males aged 60 to...


